NLRP3 and rheumatoid arthritis: We have previously demonstrated that TAK1 inhibition by LLZ reduced joint inflammation and bone destruction by inhibiting NLRP3 inflammasome and TNF-α expression in collagen-induced arthritis, a mouse model of rheumatoid arthritis [8].